HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elisabeth G E de Vries Selected Research

2- fluoro- 6- (6- hydroxynaphthalen- 2- yl)pyridin- 3- ol

11/2017In Vivo Quantification of ERβ Expression by Pharmacokinetic Modeling: Studies with 18F-FHNP PET.
4/2017Synthesis and Evaluation of the Estrogen Receptor β-Selective Radioligand 2-18F-Fluoro-6-(6-Hydroxynaphthalen-2-yl)Pyridin-3-ol: Comparison with 16α-18F-Fluoro-17β-Estradiol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elisabeth G E de Vries Research Topics

Disease

157Neoplasms (Cancer)
11/2022 - 01/2002
70Breast Neoplasms (Breast Cancer)
11/2022 - 04/2002
14Ovarian Neoplasms (Ovarian Cancer)
04/2016 - 08/2003
12Neoplasm Metastasis (Metastasis)
11/2022 - 05/2002
12Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2016 - 01/2002
11Colorectal Neoplasms (Colorectal Cancer)
11/2019 - 01/2002
10Melanoma (Melanoma, Malignant)
01/2022 - 03/2008
10Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2019 - 09/2008
10Carcinoid Tumor (Carcinoid)
10/2011 - 04/2003
6Disease Progression
11/2019 - 02/2011
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2012 - 04/2002
5Pheochromocytoma
07/2020 - 04/2003
5Colonic Neoplasms (Colon Cancer)
01/2020 - 01/2010
5Adenoma (Adenomas)
01/2018 - 01/2002
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2017 - 11/2002
5Carcinoma (Carcinomatosis)
04/2017 - 07/2003
4Carcinogenesis
05/2021 - 03/2010
4Bites and Stings (Sting)
04/2021 - 01/2016
4Lung Neoplasms (Lung Cancer)
01/2019 - 05/2006
4Testicular Neoplasms (Testicular Cancer)
01/2016 - 10/2008
4Necrosis
02/2013 - 07/2003
4Heart Failure
02/2007 - 06/2004
3Residual Neoplasm
09/2020 - 01/2002
3Renal Cell Carcinoma (Grawitz Tumor)
07/2020 - 01/2015
3Triple Negative Breast Neoplasms
01/2019 - 09/2014
3Fatigue
03/2015 - 11/2005
3Cardiotoxicity
12/2007 - 05/2006
3Chronic Obstructive Pulmonary Disease (COPD)
01/2007 - 06/2005

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
11/2022 - 04/2002
26Pharmaceutical PreparationsIBA
12/2020 - 04/2002
16Estrogen ReceptorsIBA
11/2022 - 02/2012
16LigandsIBA
01/2021 - 07/2003
15Biomarkers (Surrogate Marker)IBA
11/2018 - 08/2005
14Cisplatin (Platino)FDA LinkGeneric
01/2019 - 06/2002
14human ERBB2 proteinIBA
01/2019 - 09/2004
14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 05/2010
11Serotonin (5 Hydroxytryptamine)IBA
12/2020 - 04/2003
11Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2012 - 08/2003
10Trastuzumab (Herceptin)FDA Link
11/2018 - 09/2004
10Bevacizumab (Avastin)FDA Link
01/2017 - 07/2011
10Death Domain ReceptorsIBA
05/2012 - 08/2003
9Monoclonal AntibodiesIBA
08/2019 - 09/2004
9CatecholaminesIBA
08/2019 - 04/2003
9ErbB Receptors (EGF Receptor)IBA
01/2019 - 05/2006
9DNA (Deoxyribonucleic Acid)IBA
10/2016 - 09/2003
8Messenger RNA (mRNA)IBA
07/2020 - 09/2003
8AntibodiesIBA
01/2019 - 05/2005
889Zr-bevacizumabIBA
01/2016 - 05/2010
6MesothelinIBA
11/2022 - 09/2015
6Estradiol (Delestrogen)FDA LinkGeneric
11/2022 - 10/2015
6Immune Checkpoint InhibitorsIBA
01/2022 - 12/2018
6Hormones (Hormone)IBA
01/2019 - 07/2003
6EverolimusFDA Link
01/2017 - 01/2011
5Zirconium-89IBA
04/2021 - 07/2014
5Tyrosine Kinase InhibitorsIBA
11/2017 - 01/2010
5AnthracyclinesIBA
08/2016 - 06/2004
5PlatinumIBA
03/2016 - 06/2002
5Transforming Growth Factors (Transforming Growth Factor)IBA
01/2016 - 12/2011
5EnzymesIBA
07/2013 - 04/2003
416-fluoroestradiolIBA
11/2022 - 01/2018
4Immunoconjugates (Immunoconjugate)IBA
01/2022 - 12/2015
4Immunoglobulin G (IgG)IBA
01/2022 - 09/2004
4Biological ProductsIBA
05/2021 - 01/2002
4AntigensIBA
04/2021 - 10/2008
4Dopamine (Intropin)FDA LinkGeneric
12/2020 - 06/2010
4Fluorouracil (Carac)FDA LinkGeneric
01/2020 - 01/2002
4Insulin (Novolin)FDA Link
10/2019 - 09/2010
4Glucose (Dextrose)FDA LinkGeneric
10/2019 - 09/2009
4Dihydroxyphenylalanine (Dopa)IBA
08/2019 - 09/2009
4fluorodopa F 18IBA
03/2017 - 09/2006
4Tryptophan (L-Tryptophan)FDA Link
01/2016 - 07/2003
4TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
04/2010 - 07/2003
4multidrug resistance-associated protein 1IBA
01/2007 - 04/2002
3Biosimilar PharmaceuticalsIBA
10/2021 - 01/2018
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2021 - 03/2011
3Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2020 - 01/2015
3Androgen Receptors (Androgen Receptor)IBA
01/2019 - 12/2017
3Fluorescent Dyes (Fluorescent Probes)IBA
10/2018 - 01/2016
3Carbidopa (Lodosyn)FDA LinkGeneric
03/2017 - 09/2006
3Angiogenesis InhibitorsIBA
04/2016 - 08/2005
3Etoposide (VP 16)FDA LinkGeneric
01/2016 - 10/2008
3Bleomycin (Blenoxane)FDA LinkGeneric
01/2016 - 10/2008
3Insulin-Like PeptidesIBA
09/2014 - 01/2010
3zirconium-89-trastuzumabIBA
08/2014 - 06/2009
3Carboplatin (JM8)FDA LinkGeneric
05/2014 - 01/2002
3Proteasome Endopeptidase Complex (Proteasome)IBA
05/2012 - 04/2006
3CholesterolIBA
03/2012 - 05/2009
3TNF-Related Apoptosis-Inducing LigandIBA
02/2011 - 07/2003
3Tumor Biomarkers (Tumor Markers)IBA
01/2011 - 01/2002
3GemcitabineFDA Link
06/2010 - 09/2009

Therapy/Procedure

54Therapeutics
11/2022 - 02/2003
26Drug Therapy (Chemotherapy)
12/2021 - 01/2002
10Radiotherapy
04/2020 - 01/2002
9Immunotherapy
12/2021 - 12/2015
5Aftercare (After-Treatment)
10/2017 - 01/2002
5Adjuvant Chemotherapy
10/2017 - 07/2003
3Segmental Mastectomy (Lumpectomy)
09/2020 - 04/2006
3Chemoradiotherapy
12/2018 - 01/2015
3Neoadjuvant Therapy
03/2018 - 09/2010
3Intravenous Administration
01/2016 - 03/2009